[Retracted] Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes

Table 3

Impact of passive prescription on 6-month &1-year mortality post discharge.

Variables	Prescription Pattern	6-month mortality	value	Adjusted^# OR of 6-month mortality		value	1-year mortality	value	Adjusted^# OR of 1-year mortality		value
		No. (%)		OR	95% CI		No. (%)		OR	95% CI
Aspirin	Active	2.9	<0.001	0.436	0.225-0.845	0.014	5.7	<0.001	0.538	0.326-0.887	0.015
	Passive	7.5		1.000	Reference		13.7		1.000	Reference
Clopidogrel	Active	0.0	0.730	—	—	—	0.0	0.547	—	—	—
	Passive	0.7		—	—	—	2.2		—	—	—
Beta-Blockers	Active	2.3	0.005	0.374	0.163-0.861	0.021	5.6	0.001	0.481	0.260-0.892	0.020
	Passive	6.8		1.000	Reference		12.9		1.000	Reference
ACEI/ARBs	Active	4.8	0.919	—	—	—	6.9	0.283	—	—	—
	Passive	4.7		—	—	—	9.3		—	—	—
Statins	Active	2.4	0.014	0.538	0.326-0.887	0.125	4.6	0.001	0.514	0.277-0.956	0.036
	Passive	5.9		1.000	Reference		11.0		1.000	Reference

ACEI/ARBs, angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blockers (ARB), odds ratio (OR). ^∗All the data used in analyzing were after adjusted for age, gender, cardiovascular medical histories, diabetes, hypertension, hyperlipidemia, smoking status, discharge diagnosis.